Periodontal Ehlers-Danlos syndrome (pEDS) is an autosomal-dominant disorder characterized by early-onset periodontitis leading to premature loss of teeth, joint hypermobility, and mild skin findings. A locus was mapped to an approximately 5.8 Mb region at 12p13.1 but no candidate gene was identified. In an international consortium we recruited 19 independent families comprising 107 individuals with pEDS to identify the locus, characterize the clinical details in those with defined genetic causes, and try to understand the physiological basis of the condition. In 17 of these families, we identified heterozygous missense or in-frame insertion/deletion mutations in C1R (15 families) or C1S (2 families), contiguous genes in the mapped locus that encode subunits C1r and C1s of the first component of the classical complement pathway. These two proteins form a heterotetramer that then combines with six C1q subunits. Pathogenic variants involve the subunit interfaces or inter-domain hinges of C1r and C1s and are associated with intracellular retention and mild endoplasmic reticulum enlargement. Clinical features of affected individuals in these families include rapidly progressing periodontitis with onset in the teens or childhood, a previously unrecognized lack of attached gingiva, pretibial hyperpigmentation, skin and vascular fragility, easy bruising, and variable musculoskeletal symptoms. Our findings open a connection between the inflammatory classical complement pathway and connective tissue homeostasis.

Mitogen-activated protein kinases (MAPK) play a key role in the regulation of cellular processes such as cell growth, cell differentiation, and apoptosis. However, the specific function of single isoforms of the MAPK family in renal epithelial cell differentiation and/or proliferation has not been investigated so far. We now report stable reduction of extracellular signal-regulated kinase 1 (ERK1) protein expression and lack of serum-induced ERK1 activation in alkali-dedifferentiated Madin-Darby canine kidney-C7 focus (MDCK-C7F) cells compared with their parental epithelial MDCK-C7 cells. The changes in ERK1 protein expression and activation were accompanied by a small rise in c-jun NH2-terminal kinase 1 (JNK1) protein expression but slightly decreased basal and anisomycin-stimulated JNK1 activity. In contrast, ERK2 phosphorylation, as assessed by using an antibody which detects phosphorylated tyrosine 204 of both ERK1 and ERK2, as well as enzymatic ERK2 activity, was substantially increased in untreated and fetal calf serum-treated MDCK-C7F cells, although ERK2 protein expression remained unchanged. Differential expression and activation of ERK1, ERK2, and JNK1 were accompanied by an inhibition of serum-induced MDCK-C7F cell proliferation. Together, our results demonstrate an association between changes in the activation of certain MAPK and alkali-induced stable MDCK-C7 cell dedifferentiation. Moreover, these data provide evidence for distinct signaling functions of ERK1 and ERK2 in these cells.

Background Only a few studies directly compared virus-specific antibodies and their neutralizing capacity against SARS-CoV-2 wild type and circulating variants of concern, despite the reported high efficacy of mRNA- and vector-based vaccines. Objective Here we assessed SARS-CoV-2-S1-specific antibodies of BNT162b2, mRNA-1273 and ChAdOx1 vaccinated as well as convalescent COVID-19 patients and furthermore determined the neutralization ability against SARS-CoV-2 wild type and B.1.1.7 (Alpha), B1.1.7 E484K (Alpha E484K), B.1.351 (Beta) and B.1.617.2 (Delta) variants. Methods Serum samples of 107 fully vaccinated or convalescent individuals were analyzed for anti-SARS-CoV-2-S1 IgG and IgA as well as for total anti-SARS-CoV-2 RBD Ig. Furthermore, neutralization capacity as NT50 and NT90 values against SARS-CoV-2 wild type virus and circulating variants were determined. Results We observed a robust IgG response in all participants, however the highest titers were detected in mRNA-based vaccine recipients. In case of serum IgA responses, the difference between mRNA- and vector-based vaccines or convalescent patients was even more pronounced. Interestingly, all three vaccines could neutralize all tested VOCs in addition to wild type virus, but in some individuals only low or no neutralization especially against Alpha-E484K and Delta variant was detected. Conclusion Critically, we here studied the efficacy of various COVID-19 vaccines and found that mRNA-1273 had the highest neutralization abilities compared to BNT162b2- and ChAdOx1 vaccinees. COVID-19 convalescent patients demonstrated the most heterogeneous range of antibody titers and neutralization ability, rendering assessment of protection difficult. Furthermore a significant, positive relation between antibodies and NT50 values for immunized and convalescent individuals was determined.

Public awareness and discussion about animal experiments and replacement methods has greatly increased in recent years. The term ‘the Three Rs’, which stands for the Replacement, Reduction and Refinement of animal experiments, is inseparably linked in this context. A common goal within the Three Rs scientific community is to develop predictive non-animal models and to better integrate all available data from in vitro, in silico and omics technologies into regulatory decision-making processes regarding, for example, the toxicity of chemicals, drugs or food ingredients. In addition, it is a general concern to implement (human) non-animal methods in basic research. Toward these efforts, there has been an ever-increasing number of Three Rs centres and platforms established over recent years — not only to develop novel methods, but also to disseminate knowledge and help to implement the Three Rs principles in policies and education. The adoption of Directive 2010/63/EU on the protection of animals used for scientific purposes gave a strong impetus to the creation of Three Rs initiatives, in the form of centres and platforms. As the first of a series of papers, this article gives an overview of the European Three Rs centres and platforms, and their historical development. The subsequent articles, to be published over the course of ATLA’s 50th Anniversary year, will summarise the current focus and tasks as well as the future and the plans of the Three Rs centres and platforms. The Three Rs centres and platforms are very important points of contact and play an immense role in their respective countries as ‘on the ground’ facilitators of Directive 2010/63/EU. They are also invaluable for the widespread dissemination of information and for promoting implementation of the Three Rs in general.